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Abstract
Objective: To study the prevalence of respiratory and atopic symptoms in (young) adults born
prematurely, differences between those who did and did not develop Bronchopulmonary Disease
(BPD) at neonatal age and differences in respiratory health between males and females.
Methods: Design: Prospective cohort study.
Setting: Nation wide follow-up study, the Netherlands.
Participants: 690 adults (19 year old) born with a gestational age below 32 completed weeks and/or
with a birth weight less than 1500 g. Controls were Dutch participants of the European Community
Respiratory Health Survey (ECRHS).
Main outcome measures: Presence of wheeze, shortness of breath, asthma, hay fever and eczema
using the ECRHS-questionnaire
Results: The prevalence of doctor-diagnosed asthma was significantly higher in the ex-preterms
than in the general population, whereas eczema and hay fever were significant lower. Women
reported more symptoms than men. Preterm women vs controls: asthma 13% vs 5% (p < 0.001);
hay fever 8% vs 20% (p < 0.001); eczema 10% vs 42% (p < 0.001). Preterm men vs controls: asthma
9% vs 4% (p = 0.007); hay fever 8% vs 17% (p = 0.005); eczema 9% vs 31% (p < 0.001) Preterm
women reported more wheeze and shortness of breath during exercise (sob) than controls:
wheeze 30% vs 22% (p = 0.009); sob 27% vs 16% (p < 0.001); 19-year-old women with BPD
reported a higher prevalence of doctor diagnosed asthma compared to controls (24% vs 5% p <
0.001) and shortness of breath during exercise (43% vs 16% p = 0.008). The prevalence of reported
symptoms by men with BPD were comparable with the controls.
Conclusion: Our large follow-up study shows a higher prevalence of asthma, wheeze and
shortness of breath in the prematurely born young adults. 19-year-old women reported more
respiratory symptoms than men. Compared to the general population atopic diseases as hay fever
and eczema were reported less often.
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Neonatal respiratory distress syndrome (RDS), previously
called hyaline membrane disease, is mainly seen in pre-
term infants. The main causative factors leading to respi-
ratory distress in preterm infants are structural immaturity
of the lungs, surfactant deficiency and surfactant dysfunc-
tion. Most infants recover from RDS. However in infants
with a birth weight between 500 and 1500 gram, 3 to
43%, develop chronic lung disease (CLD), also called
bronchopulmonary dysplasia (BPD)[1,2].
High rates of respiratory illnesses and other morbidities
have been reported in survivors born prematurely in the
1970s and 1980s [3-5]. However reports on long term
outcome of respiratory health in adolescents and young
adults born prematurely are limited. This can be
explained by the continuously changing approach to the
treatment of the preterm infant with neonatal RDS, and
BPD being a relatively young disorder firstly described
about 35 years ago[1]. As the prevalence of both preterm
birth and BPD is on the rise and treatment is assessable
also in younger infants (from 25 weeks of gestational
age), the number of survivors of prematurity will
increase[6].
In most reported studies the rates of re-hospitalisation of
preterm and/or (extremely) low birth weight infants dur-
ing the first two years of life, approach or exceed 50%[7].
Overall, respiratory infections are the most common indi-
cation for re-hospitalisation[8]. The hygiene- hypothesis
states that environmental changes in the industrialised
world have lead to reduced microbial contact at an early
age and thus resulted in the growing epidemic of atopic
diseases as eczema and rhinoconjunctivitis. We were won-
dering whether the respiratory infections during early life
in preterm children resulted in a low prevalence of atopic
diseases later.
The aim of the study was to examine the presence or devel-
opment of respiratory or atopic symptoms in the whole
group of (young) adults born prematurely and specifically
if premature born did encounter irreversible injuries. In
addition, we studied differences in respiratory health at
adulthood between those who did and did not develop
BPD at neonatal age. Male gender is a risk factor for neo-
natal RDS, BPD and even death [9-12]. Boys with neona-
tal RDS seem to have more health problems than girls
during the neonatal period [13]. This lead to the question
whether we could find differences in respiratory health
between young adult males and females.
Methods
Respiratory health was studied in adults born prematurely
in a prospective cohort study. In the early eighties a
nation-wide survey was started by the Division of Perina-
tology of the Dutch Paediatric Association. Information
was collected on the incidence of very preterm and very
low birth weight infants and subsequently on their out-
come on mortality, morbidity and handicap [14,15]. Pre-
, peri-, and neonatal data of Dutch infants born alive with
a gestational age (GA) below 32 completed weeks and/or
with a birth weight less than 1500 g, were collected pro-
spectively. The study ultimately consisted of 1338 infants,
constituting 94% of the eligible infants born in 1983 in
the Netherlands. All 998 infants surviving the initial hos-
pital stay were enlisted for long term follow-up. Between
their birth and the follow up visit in 2002 379 children
died, leaving 959 living participants at age 19. BPD was
defined as clinical signs of respiratory distress, with an
abnormal chest X-ray and an oxygen requirement after 28
days of age.
The European Community Respiratory Health Survey
(ECRHS) questionnaire, was mailed to the 959 living par-
ticipants[16]. This standardised questionnaire was used to
assess the prevalence of respiratory symptoms and
asthma, in relation to well-known (environmental) risk
factors. The Dutch part of the ECRHS data in the youngest
age group (20–45 years) was used as control group (644
male and 666 female randomly selected subjects from the
general population). The study has been approved by the
Ethical Committee of TNO Leiden, the Netherlands.
Statistical analysis
Data were analysed using the Chi2test to compare the
prevalence of respiratory symptoms among both ex-pre-
terms and those of the general population. If numbers
were too small to use Chi2test, we made use of Fisher's
Table 1: Characteristics participants "Project On Preterm and Small for gestational age infants" (POPS) followed up at the age of 19 
year
total followed-up Gestational age ≤ 32 weeks Gestational age >32 weeks
n = 690 n = 508 n = 182
Gestational age (weeks), mean (range), SD 31 (26–41) ± 2.5 30 (26–32) ± 1.5 34 (32–41) ± 1.5
Birthweight (grams) mean (range), SD 1309 (560–2580) ± 293 1320 (560–2580) ± 325 1277 (600–1495) ± 175
male/female (%) 320/370 (46/54) 244/264 (48/52) 76/106 (42/58)
BPD (yes/no/unknown) (n) 58/505/127 55/362/91 3/143/36
duration mechanical ventilation (days) mean (range), SD 4.5 (0–55) ± 8.1 5.7 (0–55) ± 8.9 1.1 (0–41) ± 3.8Page 2 of 8
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Table 2: Prevalences of symptoms. The children born with a gestational age (GA) ≤ 32 weeks were compared with those born with a GA >32 weeks (birth weight (bw) <1500 g) 
and with controls according to gender
Symptom GA ≤ 32 w GA >32 w controls p-value GA ≤ 32 w 
vs controls
p-value GA >32 w 
vs controls
p-value GA ≤ 32 w 
vs GA >32w 
yes (%) yes (%) yes (%)
Have you had wheezing in
 your chest at any time in
 the last twelve months?
females 79(29.9) 32(30.5) 145(21.8) 0.009 0.05 0.9
males 42(17.4) 15(19.7) 122(18.9) 0.6 0.9 0.6
Have you had this wheezing
 when you did not have cold?
females 35(13.3) 13(12.4) 87(13.1) 0.9 0.8 0.8
males 25(10.4) 8(10.5) 73(11.3) 0.7 0.8 0.96
Are you troubled by shortness
 of breath when Hurrying on level ground
 or walking up a slight hill?
females 60(26.8) 28(34.1) 104(16.3) <0.001 <0.001 0.2
males 19(10.4) 8(12.1) 61(9.9) 0.8 0.5 0.7
Do you get short of breath
 walking with other people of your
 own age on level ground?
females 17(7.5) 6(7.5) 11(1.7) <0.001 0.001 1.0
males 5(2.8) 2(3) 9(1.5) 0.23 0.3 1.0
Do you have to stop
 for breath when walking at your
 own pace on level ground?
females 12(5.3) 4(5.1) 1(0.2) <0.001 <0.001 0.9
males 6(3.3) 0(0) 4(0.6) 0.004* 0.5 0.3
Have you ever had asthma? females 33(12.7) 7(6.7) 31(4.7) <0.001 0.3 0.1
males 21(9) 12(16) 28(4.3) 0.007 <0.001 0.08
Have you had an attack of asthma
 in the last twelve months?
females 12(4.6) 4(3.8) 15(2.3) 0.05 0.33 0.9
males 5(2.4) 2(2.7) 2(0.3) 0.004 0.009 0.7
Do you have hay fever? females 20(7.6) 8(7.5) 135(20.4) <0.001 0.002 0.9
males 23(8.4) 8(10.5) 109(17) 0.005 0.15 0.8
Do you have eczema? females 26(9.8) 9(8.5) 276(41.7) <0.001 <0.001 0.7
males 23(9.4) 8(10.5) 196(30.5) <0.001 <0.001 0.8
Respiratory Research 2005, 6:117 http://respiratory-research.com/content/6/1/117exact test. We studied the independent effects of birth
weight, gestational age, gender, duration of mechanical
ventilation, smoking habits of the parents during the
youth of the child and family history of atopic diseases
and asthma on the presence of wheeze using multiple
logistic regression analysis. Likewise we studied the inde-
pendent effect of these potential risk factors on the pres-
ence of asthma, shortness of breath (with or without
exercise), hay fever and eczema respectively. All statistical
procedures were performed using SPSS 10.0. P-values less
than 0.05 were considered to be significant (2 sided tests).
Results
The overall response rate was 72% (n = 690). Patient char-
acteristics are shown in Table 1. The non-responders were
more likely to be male, have foreign nationalities, lower
social-economic status, disabilities and lower school per-
formances at an earlier age than the responders. No differ-
ences in birth weight, gestational age or duration of
mechanical ventilation were assessed.
Premature born
The results of the analyses of the ex-preterms (GA ≤ 32
weeks) are shown in Table 2. The prevalence of doctor-
diagnosed asthma and shortness of breath during exercise
was significantly higher in the preterm than in the general
population, whereas eczema and hay fever were signifi-
cantly lower. The premature born women reported more
symptoms like wheeze than the controls. Women with a
birth weight less than 1500 gram (GA >32 weeks)
reported more often wheeze and shortness of breath but
less allergy and eczema than the female controls. We
found no such differences in males.
BPD
111 Children developed BPD (8.2%); 28 of them (25%)
died. Boys (n = 72) were more prone to develop BPD than
girls (n = 39). The response rate among BPD-patients was
69%. Since the number of BPD patients with a GA >32
weeks was only 3, we decided to analyse the results of the
patients with a GA = 32 weeks (table 3). Compared to
Table 3: Prevalence of symptoms in participants with a gestational age ≤ 32 weeks with & without BPD and controls according to 
gender
Symptom BPD No BPD controls p BPD p no BPD vs PBPD vs
yes (%) yes (%) yes (%) vs controls vs controls no BPD
Have you had wheezing
 in your chest at any time in
 the last twelve months?
females 7 (41.1) 58 (29.5) 145 (21.8) 0.06 0.025 0.3
males 9 (23.7) 25 (15.3) 122 (18.9) 0.18 0.28 0.2
Have you had this wheezing
 when you did not have cold?
females 6 (35.3) 23 (11.7) 87 (13.1) 0.008 0.6 0.006
males 4 (10.8) 15 (9.2) 73 (11.3) 0.9 0.4 0.7
Are you troubled by shortness
 of breath when Hurrying on level
 ground or walking up a slight hill?
females 6 (42.9) 41 (20.8) 104 (16.3) 0.008 0.01 0.13
males 3 (12.0) 13 (10.2) 61 (9.9) 0.7 0.9 0.7
Do you get short of breath
 walking with other people of
 your own age on level ground?
females 0 (0) 12 (7.1) 11 (1.7) 0.6 <0.001 0.6
males 0 (0) 5 (3.9) 9 (1.5) 0.5 0.06 0.6
Do you have to stop
 for breath when walking at your
 own pace on level ground?
females 0 (0) 6 (3.6) 1 (0.2) 0.8 <0.001 1.0
males 0 (0) 6 (4.7) 4 (0.6) 0.7 <0.001 0.6
Have you ever had asthma? females 4 (23.5) 23 (12) 31 (4.7) <0.001 <0.001 0.2
males 3 (8.1) 13 (8.2) 28 (4.3) 0.28 0.05 1.0
Have you had an attack of
 asthma in the last twelve months?
females 1 (6.25) 10 (17.2) 15 (2.3) 0.32 0.007 1.0
males 0 (0) 4 (2.5) 2 (0.3) 0.73 0.004 0.5
Do you have hay fever? females 1 (5.9) 16 (8.1) 135 (20.4) 0.13 <0.001 0.7
males 1 (2.6) 20 (12) 109 (17) 0.02 0.1 0.1
Do you have eczema? females 5 (29.4) 18 (9.1) 276 (41.7) 0.3 <0.001 0.01
males 3 (7.9) 13 (7.9) 196 (30.5) 0.002 <0.001 1.0Page 4 of 8
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Respiratory Research 2005, 6:117 http://respiratory-research.com/content/6/1/117female controls, 19-year-old females with BPD reported a
higher prevalence of doctor-diagnosed asthma, wheeze
and shortness of breath during exercise. The BPD males
reported significant less hay fever and eczema than the
male controls.
Respiratory symptoms and atopy
In regression analyses dyspnea, asthma, wheeze, dyspnea
on exertion, hay fever and eczema were assessed as out-
come parameters. Dyspnea was significantly related to
long term mechanical ventilation and BPD, maternal
asthma and current smoking. An inverse relation was
found with gestational age. Asthma was significantly
related to maternal asthma. Wheeze was significantly
related to female gender and current smoking habits and
tended to be related to maternal smoking during the
youth of the participant. Shortness of breath during exer-
cise was related to female gender and smoking in the past.
We found no significant associations of birth weight, ges-
tational age, duration of mechanical ventilation, gender,
smoking habits or BPD to hay fever and eczema (see table
4). Young adults with recurrent respiratory infections in
infancy reported more asthmatic symptoms than those
without respiratory infections (p < 0.001). No significant
differences were found between recurrent respiratory
infections and hayfever or eczema. Young adults with sep-
sis during the neonatal period reported less hayfever than
those without sepsis (p = 0.03), but no significant differ-
ences were found between sepsis and asthma or eczema.
Discussion
In this long-term follow-up of ex-preterms into adulthood
we found a higher prevalence of asthma, wheezing and
shortness of breath during exercise in the ex-preterms
(especially the women) compared to the general popula-
tion. Atopy (i.e. hay fever, rhino-conjunctivitis and atopic
dermatitis) was significantly lower in the ex-preterms
compared with the controls. In this study, we did not per-
form lung function, skin prick or RAST tests to confirm the
diagnoses. However, the relation between subject
reported symptoms on the basis of the used ECHRS ques-
tionnaire and lung function is studied earlier. Subject
reported symptoms were related to impaired lung func-
tion and to increased variability of peak flow[17].
Long-term reports on respiratory health in infants born
prematurely are limited and contradictory. Respiratory
health of preterm children of birth weight ≤ 1500 g at 14
years of age has been reported to be comparable to that of
term controls [18]. Others found that infants born prema-
turely with and without a history of neonatal RDS, but
who did not develop BPD, have an increased prevalence
of airway hyperreactivity compared to full term controls
which can persist into early adult life [3,4]. At school age
bronchial obstruction and increased bronchial respon-
siveness have been demonstrated in prematurely born
children [19].
Preterm birth and asthma
The pathophysiology of neonatal RDS is not completely
understood, but it has been demonstrated that factors
such as mechanical ventilation and oxygen lead to an
inflammatory process, which could result in an early Th1-
response. Moreover, in most reported studies the rates of
re-hospitalisation of preterm and/or (extremely) low birth
weight infants during the first two years of life, approach
Table 4: Odds ratios (95% confidence intervals) for respiratory symptoms, hay fever and eczema, determined by multiple regression 
analysis. Significant relations are printed in bold. Birth weight, gestational age, duration of mechanical ventilation and smoking habits 
are entered as categorical covariates.
dyspnea asthma wheeze SOBDE* hayfever eczema
birth weight (gram) 500–1000 0.4 (0.2–1.1) 0.6 (0.2–2.4) 1.6 (0.7–4.0) 0.6 (0.2–1.9) 1.2 (0.3–4.4) 1.2 (0.3–4.5)
1000–1500 0.5 (0.3–1.2) 0.8 (0.3–2.0) 1.7 (0.8–3.6) 1.0 (0.4–2.3) 1.4 (0.5–3.6) 1.5 (0.6–4.3)
Gestational age 
(weeks)
till 28 0.4 (0.2–0.9) † 0.8 (0.2–2.6) 0.9 (0.4–1.9) 1.1 (0.5–2.7) 1.3 (0.4–4.2) 0.9 (0.3–2.7)
28–31 0.5 (0.2–0.9) † 1.1 (0.4–2.6) 1.0 (0.6–1.9) 0.7 (0.3–1.4) 1.2 (0.5–2.9) 0.9 (0.4–2.3)
Mechanical 
ventilation (days)
1–7 days 1.1 (0.6–216) 1.3 (0.6–3.1) 1.0 (0.5–1.9) 1.1 (0.5–2.2) 1.4 (0.6–3.2) 1.21 (0.5–2.8)
8–28 days 0.9 (0.4–2.2) 0.3 (0.1–1.5) 1.2 (0.6–2.6) 0.7 (0.3–1.9) 0.7 (0.2–2.3) 1.1 (0.4–3.4)
>28 5.2 (1.2–23.3) † 0.3 (0.0–4.0) 1.6 (0.4–6.9) 0.2 (0.2–2.7) 0.7 (0.1–7.7) 0.4 (0.0–3.7)
female gender 1.6 (1.0–2.7) 1.2 (0.6–2.3) 2.0 (1.2–3.2) † 3.8 (2.0–7.3) ‡ 0.7 (0.1–7.7) 1.3 (0.7–2.5)
Maternal smoking 1.1 (0.6–1.9) 1.6 (0.7–3.5) 1.6 (1.0–2.8) 1.3 (0.7–2.5) 0.6 (0.3–1.3) 1.0 (0.5–2.1)
Maternal asthma 2.5 (1.2–5.4) † 4.2 (1.8–10.5) ‡ 1.3 (0.6–2.9) 1.6 (0.6–4.1) 1.8 (0.6–5.2) 2.0 (0.7–5.3)
BPD 3.1 (1.2–8.2) † 3.1 (0.7–14.6) 1.5 (0.6–3.6) 2.0 (0.6–6.9) 0.4 (0.1–2.3) 2.4 (0.8–7.4)
Smoking participant past 1.2 (0.6–2.5) 0.6 (0.2–1.7) 0.9 (0.4–1.9) 2.2 (1.0–4.8) † 1.5 (0.6–3.6) 1.4 (0.6–3.4)
"party" 0.5 (0.1–1.5) 0.9 (0.3–2.9) 1.9 (0.8–4.0) 0.9 (0.3–2.5) 0.3 (0.0–2.3) 1.3 (0.5–3.8)
daily 2.7 (1.5–5.1) ‡ 0.4 (0.1–1.1) 2.6 (1.5–4.6) ‡ 1.5 (0.7–2.9) 1.6 (0.7–3.7) 1.0 (0.4–2.5)
*SOBDE = shortness of breath during exercise, † p < 0.05, ‡ p = 0.001Page 5 of 8
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Respiratory Research 2005, 6:117 http://respiratory-research.com/content/6/1/117or exceed 50%[7]. Respiratory illnesses and especially res-
piratory infections are the most common indication for
re-hospitalisation in this patient group. Also in our cohort
the re-hospitalisation-rate in early childhood was high
(34%)[14]. In contrast re-admission rates for normal
birth weight infants are much lower (about 20%)[7].
Asthma is often characterised by symptoms like shortness
of breath and wheeze; reversible airway obstruction; air-
way hyper-responsiveness and airway inflammation. In
children and young adults, asthma is associated with
atopy through IgE-dependent mechanisms, and airway-
inflammation is partly related to helper T type 2 (Th2)
lymphocytes and eosinophil mediation [20]. Preterm
born adults report asthma-like symptoms, but less allergy
compared to controls. Decreased risk of atopy is also
found in a Finnish prospective birth cohort study compar-
ing term and preterm adults: high gestational age
increased the risk of atopy at the age of 31[21]. The early
Th1- response, in combination with serious infections in
the first two years of life, could be an explanation for the
lower prevalence of atopy, which is in line with the
hygiene-hypothesis [22]. Others found that children who
were septic in the neonatal period were less likely to have
asthma[23]. We could not confirm this. However, young
adults who were septic during the neonatal period did
report less hayfever. In our study, adults with recurrent
respiratory infections in infancy did not report less but
more asthma. This is remarkable considering that early
exposure to endotoxins or other allergens enhance Th1-
type cytokine responses tip the balance away from Th2-
type responses that favour the development of allergic dis-
eases including asthma[24]. The high rate of respiratory
symptoms might be due to sustained increased vulnera-
bility of the immature airways in a way that mimics
asthma, but is not exactly the same.
Gender
Male gender is a risk factor for neonatal RDS and BPD [9-
11]. Boys with neonatal RDS seem to have more health
problems than girls during the neonatal period and
school age[13,23]. However, long-term outcome shows
gender differences in e.g. school-performances, but not in
respiratory health. We found that particularly women
reported symptoms as wheeze and shortness of breath. In
the 'general' population both incidence and prevalence of
wheeze and asthma is higher in males than in females
until the age of 16 year [25,26]. In adulthood, asthma
occurs more frequently among women[25,26]. The
observed variation between males and females in the gen-
eral population has partly been explained by dys-synnap-
tic lung growth: the independent growth of the airways in
comparison with the lung parenchyma and air spaces. In
girls, growth of the airways is proportional to growth of
lung parenchyma, whereas in boys growth of the airways
lags behind that of lung parenchyma, causing a discrep-
ancy between airway and lung size [27]. Different puber-
tal patterns of thoracic growth between the sexes results in
an approximately 25% higher lung function in males than
in females of identical height at the end of puberty. We
speculate that a similar process takes place in the preterm
born population, although the underlying mechanism is
not understood. Another explanation might be that large
individual differences exist in physical symptom reports.
Women may require a greater amount of cognitive analy-
sis (and thus more attention) to make judgements about
physical symptoms compared to men[28].
There have been few reports of respiratory health during
exercise. Our finding of a high percentage of participants
that reported shortness of breath during exercise, is in
agreement with a study showing low oxygen consumption
in low birth weight children compared to children with a
normal birth weight [29]. The authors suggested that
extremely low birth weight children have a lower level of
fitness than controls.
BPD
Airway obstruction and airway hyper-reactivity persisted
in children and adolescents with BPD [3,4,30]. Long-term
studies in children who had BPD as infants showed per-
sisting lung function abnormalities consisting of airway
obstruction, airway hyper-reactivity, and hyperinfla-
tion[5,31]. Both BPD and asthma are characterised by
increased smooth muscle contraction and symptoms of
both diseases are therefore perhaps difficult to distin-
guish. As stated above, airway inflammation is an impor-
tant feature in children and adults with asthma. Studies
showed that inflammation plays an important role in the
pathogenesis of BPD. Contrary to asthma, however, the
BAL-fluid reflects a Th1-cell subtype[32,33]. Even more
than preterm infants without BPD, infants with BPD are
likely to be re-hospitalised early in childhood with a res-
piratory illness[8,34]. The same mechanism as described
above could be an explanation for the low prevalence of
hay fever and eczema, despite the asthma-like symptoms.
Analysis of risk factors for respiratory symptoms
The regression analysis confirmed the association
between dyspnea and respectively long-term mechanical
ventilation, BPD and smoking of the participant. We
expected to find high risks for respiratory symptoms in the
young adults with a (very) low birth weight or born (very)
prematurely due to the immaturity of the airways at birth.
However, the degree of prematurity or dysmaturity did
not increase the risk at all. As a matter of fact, the risk for
dyspnea was even lower in the children born very prema-
turely. In seeking to understand this we speculate that
these young adults have a bias toward symptom detection
and the feeling of distress because they are used to physi-
cal limitations. Future research should investigate thePage 6 of 8
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Respiratory Research 2005, 6:117 http://respiratory-research.com/content/6/1/117extend to which physical symptoms correlate with lung
function abnormalities.
A limitation of our study might be that the age range of
the preterms and the general population sample is not
exactly the same. However, the prevalence of respiratory
symptoms is probably increasing with age. Therefore, the
differences might even be more obvious when the results
of young adults born prematurely could be compared
with peers from the general population. As the complete
cohort was inhomogeneous in the sense that it consisted
of either preterm or small for gestational age infants, we
choose to analyse the data of the preterm children (GA ≤
32 weeks). The possibility that symptoms will disappear
and that ex-preterms will "grow out" of their disease after
adolescence is likely to be very small because the lungs
stop growing and developing after that age. It might even
be possible that symptoms come back or become more
severe during adulthood, as has been observed in long-
term follow-up of asthma[35].
Conclusion
Our study clearly demonstrated that more than a third of
young adults born preterm suffer from respiratory symp-
toms (higher prevalence of asthma, wheeze and shortness
of breath) and need more medical care than peers. Not
only paediatricians, but also family doctors and chest phy-
sicians should be aware of this 'new' group of patients in
which respiratory symptoms will never disappear. Espe-
cially women seem to be more vulnerable on their way to
adulthood and report more respiratory symptoms than
controls. Future research should investigate to what
extend physical symptoms correlate with lung function
abnormalities. On the other hand, our findings are
encouraging because a lot of young adults born preterm,
survive with no or only minor respiratory problems and
compared to the general population atopic diseases as hay
fever and eczema were reported less often.
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